Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell Transcriptomics Reveals Early Molecular and Immune Alterations Underlying the Serrated Neoplasia Pathway Toward Colorectal Cancer. | Cell Mol Gastroenterol Hepatol | 2023 | 36216310 | PubTator, text mining | PubMed |
| CD56bright CD16- natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease. | Haematologica | 2023 | 36200416 | PubTator, text mining | PubMed |
| Human Cardiac Pericytes Are Susceptible to SARS-CoV-2 Infection. | JACC Basic Transl Sci | 2023 | 36124009 | PubTator, text mining | PubMed |
| Early expression of CD94 and loss of CD96 on CD8+ T cells after allogeneic stem cell tranplantation is predictive of subsequent relapse and survival. | Haematologica | 2023 | 35924575 | PubTator, text mining | PubMed |
| COVID-19 and renal involvement: a prospective cohort study assessing the impact of mild SARS-CoV-2 infection on the kidney function of young healthy males. | Int Urol Nephrol | 2023 | 35877031 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients. | Gut | 2023 | 35361683 | PubTator, text mining | PubMed |
| Acute Kidney Injury in Elderly Patients With Coronavirus Infectious Disease: A Study of Incidence, Risk Factors, and Prognosis in Brazil. | Front Nephrol | 2022 | 37675003 | PubTator, text mining | PubMed |
| Oral cavity infection by the SARS-CoV-2: emphasizing the essence of masking and peptide therapeutics. | Egypt J Med Hum Genet | 2022 | 37521842 | PubTator, text mining | PubMed |
| Cereals as a Source of Bioactive Compounds with Anti-Hypertensive Activity and Their Intake in Times of COVID-19. | Foods | 2022 | 37430980 | PubTator, text mining | PubMed |
| A Preliminary Study of Frequency and Clinical Relevance of Cytotoxic Peripheral CD4 and CD8 T Cells in Patients with Anti-MDA5 Positive Dermatomyositis. | Rheumatol Immunol Res | 2022 | 36788974 | PubTator, text mining | PubMed |
| Single-cell RNA-seq reveals cellular heterogeneity from deep fascia in patients with acute compartment syndrome. | Front Immunol | 2022 | 36741388 | PubTator, text mining | PubMed |
| The role of oxidative stress in the pathogenesis of infections with coronaviruses. | Front Microbiol | 2022 | 36713204 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the molecular features of peripheral blood immune cells in children, adults and centenarians. | Front Immunol | 2022 | 36703979 | PubTator, text mining | PubMed |
| Comparative analysis of thoracic and abdominal aortic aneurysms across the segment and species at the single-cell level. | Front Pharmacol | 2022 | 36703732 | PubTator, text mining | PubMed |
| Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination. | Front Immunol | 2022 | 36685601 | PubTator, text mining | PubMed |
| A new natural killer cell-specific gene signature predicting recurrence in colorectal cancer patients. | Front Immunol | 2022 | 36685584 | PubTator, text mining | PubMed |
| A high interferon gamma signature of CD8+ T cells predicts response to neoadjuvant immunotherapy plus chemotherapy in gastric cancer. | Front Immunol | 2022 | 36685525 | PubTator, text mining | PubMed |
| NK- and T-cell granzyme B and K expression correlates with age, CMV infection and influenza vaccine-induced antibody titres in older adults. | Front Aging | 2022 | 36685324 | PubTator, text mining | PubMed |
| Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature. | Medicina (Kaunas) | 2022 | 36676691 | PubTator, text mining | PubMed |
Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review. | Cancer Drug Resist | 2022 | 36627894 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=46